Madi Madiyalakan is the founder of OncoQuest. OncoQuest has raised $13M in total funding. Backed by Hepalink USA Inc.. Based in Edmonton, Canada.
Madi Madiyalakan is the CEO of OncoQuest, a privately held, Canadian-based pharmaceutical company focused on developing and commercializing immunotherapies for cancer. OncoQuest's technology platform includes tumor antigen specific monoclonal immunoglobulins and combinatorial immunotherapy. The company raised $13 million in a private placement led by Hepalink USA Inc. in 2015 to fund its immunotherapy drug development program.
Full founder directory · Investor directory · Company funding database · Fundraising library